BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Biotech Beach

  Study Published In Journal Of Glaucoma Evaluates A Single Glaukos iStent Trabecular Micro-Bypass Stent As A Standalone Procedure

  December 12, 2016

   · 

  7 min read
• Drug Development

  Interim Results From Phase 1b/2 Study Evaluating The Combination Of Merck & Co.’s KEYTRUDA (Pembrolizumab) And Eisai Inc.’s HALAVEN (Eribulin Mesylate) Injection In Metastatic Triple-Negative Breast Cancer Presented At 2016 SABCS

  December 12, 2016

   · 

  1 min read
• Business

  Almirall And Nuevolution Enter Into A Strategic Collaboration To Develop ROR?t Inhibitors For Treatment Of Dermatology Diseases & Psoriatic Arthritis

  December 12, 2016

   · 

  4 min read
• Oxford Nanopore Announces £100M / $126M Fundraising

  December 12, 2016

   · 

  4 min read
• Drug Development

  Seattle Genetics Highlights Phase 1 Data For Novel Antibody-Drug Conjugate SGN-LIV1A In Patients With Metastatic Breast Cancer At San Antonio Breast Cancer Symposium

  December 12, 2016

   · 

  7 min read
• Business

  Jaguar Animal Health And Henry Schein Sign Exclusive Distribution Agreement For Neonorm Foal

  December 12, 2016

   · 

  5 min read
• Drug Development

  Syros Pharma Presents New Preclinical Data Demonstrating Significant Anti-Proliferative Effects Of Its First-in-Class Selective RARa Agonist In Genomically Defined Subsets Of Breast Cancer

  December 12, 2016

   · 

  6 min read
• Drug Development

  AXON Neuroscience’s Alzheimer Tau Vaccine Phase 1 Study Results Published In Lancet Neurology

  December 12, 2016

   · 

  3 min read
• Drug Development

  NantKwest Announces Enhanced High-Affinity Activated Natural Killer (Hank) Cell Therapy In Preclinical Studies Of HER2 Positive Breast Cancer At Presentation At The San Antonio Breast Cancer Symposium

  December 12, 2016

   · 

  4 min read
• BioCapital

  CEL-SCI Reports On NYSE MKT Noncompliance Notice And Compliance Plan

  December 12, 2016

   · 

  5 min read